Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment
The drug, sold under the name Mavyret, can cure all six genetic types of the liver disease in eight weeks at a cost of $26,400, well below other options.
The independent source for health policy research, polling, and news.
1,041 - 1,060 of 1,871 Results
The drug, sold under the name Mavyret, can cure all six genetic types of the liver disease in eight weeks at a cost of $26,400, well below other options.
Medicaid covers about two-thirds of nursing home residents, but it pays less than other types of insurance.
The clinics, which serve many poor people, are tightening spending in case Congress doesn’t approve new funding for them before the government’s 2018 fiscal year starts Sunday.
The statement from the Maine senator came after the Congressional Budget Office said the bill would cause millions of people to become uninsured.
Those relying on the federal government’s safety net are grandmothers, the kid next door, your supermarket cashier — maybe even you.
The measure proposed by Sens. Lindsey Graham (R-S.C.) and Bill Cassidy (R-La.) would disrupt the existing health system more than any of the measures considered so far this year, according to supporters and critics.
Republicans are making a concerted push to unite around a bill sponsored by Sens. Lindsey Graham and Bill Cassidy that would gut major provisions of the federal health law.
Census Bureau reports that 28.1 million people in the country were without insurance in 2016, down from 29 million the year before.
To strengthen your core knowledge of health care policy, it helps to be a regular reader of Kaiser Health News. Here's a pop quiz to gauge what you have learned.
Under a five-year agreement with the federal government, California is using Medicaid dollars to expand drug treatment, including more inpatient care and a broader range of medications.
The Senate Finance Committee begins hearings Thursday on the program, which provides coverage to more than 9 million children and is up for renewal on Sept. 30.
The Deferred Action for Childhood Arrivals program made it possible for young adults who came into the country illegally as children to get jobs with insurance and, in some states including California, Medicaid. Now that coverage is in peril.
New research offers evidence that coverage expansion policies for adults have a positive spillover effect for kids.
As lawmakers look for ways to stabilize the health law marketplaces, a number of ideas — such as expanding who can “buy in” to Medicare and Medicaid or pushing young adults off their parents’ plans into the marketplaces — might come into play.
Medicaid spent billions more in 2016 than the year before on decades-old prescription drugs, including many generics, a Kaiser Health News data analysis shows.
Advocates say California’s Medicaid program is violating its own rules by overturning decisions that would allow seriously ill patients to stay out of managed care and keep their doctors.
A Medicaid-funded effort in San Antonio seeks to test vulnerable populations for latent TB infections.
The expansion of the Nurse-Family Partnership, financed initially by the federal government and several philanthropies, must meet specific goals to get state contributions. Officials hope to add 3,200 women to the program.
The high cost of Spinraza, a new and promising treatment for spinal muscular atrophy, highlights how the cost-benefit analysis insurers use to make drug coverage decisions plays out in human terms.
Tighter Medicaid budgets could jeopardize states’ home-based services that help older adults and disabled people live in their homes instead of more expensive nursing homes.
© 2026 KFF